Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA
Eurosida Study Grp, Amele S, Peters L, Sluzhynska M, Yakovlev A, Scherrer A, et al
HIV MEDICINE 2019;20(4):264-273

Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers
Giardina F, Romero-severson Eo, Axelsson M, Svedhem V, Leitner T, Britton T, et al
International journal of epidemiology 2019;():-

Differential item functioning for items in Berger's HIV Stigma Scale: an analysis of cohorts from the Indian, Swedish, and US contexts
Reinius M, Rao D, Manhart Le, Wiklander M, Svedhem V, Pryor J, et al
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2018;27(6):1647-1659

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Sörstedt E, Carlander C, Flamholc L, Hejdeman B, Svedhem V, Sönnerborg A, et al
International journal of antimicrobial agents 2018;51(5):733-738

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
Andersson E, Nordquist A, Esbjörnsson J, Flamholc L, Gisslén M, Hejdeman B, et al
AIDS (London, England) 2018;32(7):877-884

Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden
De Coninck Z, Hussain-alkhateeb L, Bratt G, Ekström Am, Gisslén M, Petzold M, et al
AIDS patient care and STDs 2018;32(8):297-305

The Relationship Between Stigma and Health-Related Quality of Life in People Living with HIV Who Have Full Access to Antiretroviral Treatment: An Assessment of Earnshaw and Chaudoir's HIV Stigma Framework Using Empirical Data
Reinius M, Wiklander M, Wettergren L, Svedhem V, Eriksson Le
AIDS and behavior 2018;22(12):3795-3806

A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model
Brännström J, Sönnerborg A, Svedhem V, Neogi U, Marrone G
HIV medicine 2017;18(9):677-684

Development of a 12-item short version of the HIV stigma scale
Reinius M, Wettergren L, Wiklander M, Svedhem V, Ekström Am, Eriksson Le
Health and quality of life outcomes 2017;15(1):115-

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014
Häggblom A, Lindbäck S, Gisslén M, Flamholc L, Hejdeman B, Palmborg A, et al
PloS one 2017;12(2):e0171227-

Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets
Gisslén M, Svedhem V, Lindborg L, Flamholc L, Norrgren H, Wendahl S, et al
HIV medicine 2017;18(4):305-307

Deficiencies in the health care system contribute to a high rate of late HIV diagnosis in Sweden
Brännström J, Svedhem Johansson V, Marrone G, Wendahl S, Yilmaz A, Blaxhult A, et al
HIV medicine 2016;17(6):425-35

High Concordance between Self-Reported Adherence, Treatment Outcome and Satisfaction with Care Using a Nine-Item Health Questionnaire in InfCareHIV
Marrone G, Mellgren Å, Eriksson Le, Svedhem V
PloS one 2016;11(6):e0156916-

Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden
Carlander C, Wagner P, Svedhem V, Elfgren K, Westling K, Sönnerborg A, et al
International journal of cancer 2016;139(7):1471-9

Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study
Brännström J, Svedhem V, Marrone G, Andersson Ö, Azimi F, Blaxhult A, et al
PloS one 2016;11(9):e0162503-

Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden
Häggblom A, Svedhem V, Singh K, Sönnerborg A, Neogi U
The lancet. HIV 2016;3(4):e166-74

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study
Hides Audit Study Group, Raben D, Mocroft A, Rayment M, Mitsura Vm, Hadziosmanovic V, et al
PloS one 2015;10(11):e0140845-

Development and psychometric testing of a barriers to HIV testing scale among individuals with HIV infection in Sweden; The Barriers to HIV testing scale-Karolinska version
Wiklander M, Brännström J, Svedhem V, Eriksson Le
Health and quality of life outcomes 2015;13():185-

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues
Antinori A, Clarke A, Svedhem-johansson V, Arribas Jr, Arenas-pinto A, Fehr J, et al
AIDS (London, England) 2015;29(14):1811-20

Psychometric evaluation of the HIV stigma scale in a Swedish context
Lindberg Mh, Wettergren L, Wiklander M, Svedhem-johansson V, Eriksson Le
PloS one 2014;9(12):e114867-

Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients with HIV Type 1 Infection
Jansen K, Sonnerborg A, Brockmeyer N, Thalme A, Svedhem V, Dupke S, et al

Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients with HIV Type 1 Infection
Jansen K, Sonnerborg A, Brockmeyer N, Thalme A, Svedhem V, Dupke S, et al

Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIV
Svedhem-johansson V, Pugliese P, Brockmeyer Nh, Thalme A, Michalik C, Esser S, et al
Current HIV research 2013;11(4):333-41

Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients
Eden A, Andersson Lm, Andersson O, Flamholc L, Josephson F, Nilsson S, et al

Presence of M184I/V in minor HIV-1 populations of patients with lamivudine and/or didanosine treatment failure
Svedhem V, Bergroth T, Lidman K, Sönnerborg A
HIV medicine 2007;8(8):504-10

Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir
Svedhem V, Lindkvist A, Bergroth T, Knut L, Sönnerborg A
Journal of medical virology 2005;76(4):447-51

Disseminated infection with encephalitozoon intestinalis in AIDS patients: report of 2 cases
Svedhem V, Lebbad M, Hedkvist B, Del Aguila C, Hedman P, Larsson R, et al
Scandinavian journal of infectious diseases 2002;34(9):703-5

Persistence of earlier HIV-1 drug resistance mutations at new treatment failure
Svedhem V, Lindkvist A, Lidman K, Sönnerborg A
Journal of medical virology 2002;68(4):473-8

Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy
Birk M, Svedhem V, Sönnerborg A
AIDS (London, England) 2001;15(11):1359-68

Uptake of 111In-pentetreotide and 99mTc-labeled autologous granulocytes in Kimura's disease
Von Sivers K, Kettis Aa, Svedhem V, Sandstedt B, Garmelius B, Jacobsson H
European radiology 2000;10(6):1026-8

Microsporidia in duodenal biopsies from 72 HIV-infected patients with abdominal complaints
Svedhem V, Lebbad M, Struve J, Veress B, Andström E, Aust-kettis A, et al
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(5):535-8

Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy
Hammarin Al, Bogdanovic G, Svedhem V, Pirskanen R, Morfeldt L, Grandien M
Journal of clinical microbiology 1996;34(12):2929-32

Visa alla publikationer